The board of directors of Tongfang Kontafarma Holdings Limited announced that Chai Hongjie, who has acted as the executive Director and the chairman of the Board since September 3, 2020, ceased to act as the chairman of the Board with effect from April 19, 2022 and Bai Pingyan, who has acted as the executive Director since September 27, 2021, takes up the role of the chairman of the Board with effect from April 19, 2022. Chai is currently the chairman of each of the executive committee, the nomination committee, the share dealing committee and the investment committee of the Board, while Bai is a member of each of the Executive Committee and the Share Dealing Committee. With effect from April 19, 2022, Bai also takes up the role of the chairman of each of the Executive Committee, the Nomination Committee, the Share Dealing Committee and the Investment Committee and Chai remains a member of each of the Executive Committee and the Share Dealing Committee.

Both Chai and Bai will remain to serve as executive Directors and there is no other change to the composition of the Board or of its committees as a result of the foregoing save as disclosed above.